KRAS/LKB1-mutant lung cancer cells are more dependent on an unorthodox pathway of pyrimidine biosynthesis that utilizes mitochondrially generated carbamoyl phosphate through upregulation of carbamoyl phosphate synthetase-1 (CPS1; Kim et al., 2017). The gene discussed is KRAS; the disease is lung cancer.